OppenheimerFunds’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$19.8M Sell
139,769
-52,507
-27% -$7.1M 0.02% 542
2018
Q4
$22.3M Sell
192,276
-84,748
-31% -$11.1M 0.03% 472
2018
Q3
$41.2M Sell
277,024
-88,102
-24% -$11.2M 0.05% 384
2018
Q2
$35.8M Sell
365,126
-41,664
-10% -$3.63M 0.04% 417
2018
Q1
$33M Buy
406,790
+205,946
+103% +$16.6M 0.04% 422
2017
Q4
$15.4M Buy
200,844
+124,161
+162% +$8.96M 0.02% 663
2017
Q3
$5.27M Buy
76,683
+4,830
+7% +$314K 0.01% 809
2017
Q2
$4.97M Sell
71,853
-26,916
-27% -$1.65M 0.01% 818
2017
Q1
$4.5M Buy
98,769
+33,229
+51% +$1.74M 0.01% 850
2016
Q4
$3.56M Buy
65,540
+21,912
+50% +$1.2M ﹤0.01% 863
2016
Q3
$2.54M Buy
43,628
+149
+0.3% +$8.21K ﹤0.01% 869
2016
Q2
$2.17M Buy
43,479
+14,001
+47% +$748K ﹤0.01% 873
2016
Q1
$1.9M Sell
29,478
-6,053
-17% -$359K ﹤0.01% 887
2015
Q4
$2.14M Buy
+35,531
New +$2.24M ﹤0.01% 900

Other funds holding MOH

OppenheimerFunds's MOH Position: Q1 2019 in Review

OppenheimerFunds reduced its Molina Healthcare (MOH) stake by 27% in Q1 2019, selling an estimated $7.1M and leaving 139,769 shares worth $19.8M. The position accounts for 0.02% of the portfolio, ranked #542.

OppenheimerFunds first reported a position in MOH in Q4 2015 and has held it in 14 quarters since. The position peaked at $41.2M in Q3 2018. 350 funds tracked by Wall St. Rank hold MOH as of Q1 2019.

  • OppenheimerFunds held 139,769 shares of Molina Healthcare worth $19.8M as of Q1 2019.
  • OppenheimerFunds sold 52,507 Molina Healthcare shares in Q1 2019, an estimated $7.1M.
  • Molina Healthcare made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #542 holding.
  • OppenheimerFunds first reported a position in Molina Healthcare in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Molina Healthcare position peaked at $41.2M in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Molina Healthcare as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.